Skip to main content

Find Clinical Trials

Home
Conditions
Fallopian Tube Diseases

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

NCT01220154

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: OSU Gyn Oncology at Mill Run Hilliard, Ohio, United States

View Trial Details

Completed

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT03552471

Conditions: Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +24 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer

NCT04406623

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: City of Hope Duarte, California, United States

START Midwest Grand Rapids, Michigan, United States

University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

Stephenson Cancer Center at Oklahoma University Oklahoma City, Oklahoma, United States

View Trial Details

Completed

KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer

NCT05256576

Conditions: Adnexal Diseases, Behavior, Endocrine Gland Neoplasms, +26 more
Locations: Evangelische Kliniken Essen Mitte Essen, North Rhine-Westphalia, Germany

Charité University Hospital Berlin Berlin, State of Berlin, Germany

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02042430

Conditions: Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +24 more
Locations: University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02312245

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Mayo Clinic in Arizona Phoenix, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Homologous Recombination Inquiry Through Ovarian Malignancy Investigations

NCT03159572

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Niigata University Graduate School of Medical and Dental Sciences Niigata, Japan

View Trial Details

Completed

Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation

NCT02953457

Conditions: Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +20 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

The Feinstein Institute for Medical Research/Lennox Hill Hospital New York, United States

View Trial Details

Completed

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

NCT04227522

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations: Universitätsklinikum Aachen Aachen, Germany

ANregiomed Frauenklinik Ansbach Ansbach, Germany

Helios Klinikum Berlin-Buch Berlin, Germany

Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany

View all 17 locations

View Trial Details